Meropenem Clinical Trials
7 recruitingDrug
Phase 44Phase 21Phase 31Not Applicable1
Showing 1–7 of 7 trials
Recruiting
Not Applicable
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactam+6 more
University Hospital, Ghent300 enrolled3 locationsNCT06426836
Recruiting
Phase 4
PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
Enterobacteriaceae InfectionsBacteremiaBeta Lactam Resistant Bacterial Infection
Rambam Health Care Campus1,084 enrolled14 locationsNCT03671967
Recruiting
Phase 4
Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Carbapenem Resistant Bacterial InfectionAcinetobacter BacteremiaAcinetobacter Pneumonia
Rambam Health Care Campus734 enrolled3 locationsNCT05922124
Recruiting
Phase 4
Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis
SepsisSeptic Shock
Scandinavian Critical Care Trials Group5,800 enrolled2 locationsNCT06184659
Recruiting
Phase 4
Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens
Febrile Neutropenia
Beneficência Portuguesa de São Paulo176 enrolled1 locationNCT06342115
Recruiting
Phase 2
A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia
Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)
Jiangsu HengRui Medicine Co., Ltd.100 enrolled1 locationNCT06841731
Recruiting
Phase 3
Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit
SepsisSeptic Shock
Assistance Publique - Hôpitaux de Paris600 enrolled2 locationsNCT05565222